Effect of 2′-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells

Nucleic Acids Research

Volumn 29, Issue 2, 2001, Pages 415-422

  Schmitz, John C ^a   Yu, Dong ^b   Agrawal, Sudhir ^b   Chu, Edward ^a  

^a YALE CANCER CENTER   (United States)

^b HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CIS ACTING ELEMENT; DNA TOPOISOMERASE; FLUOROURACIL; MESSENGER RNA; NUCLEOTIDE; PROTEIN P53; RALTITREXED; THYMIDYLATE SYNTHASE; ENZYME INHIBITOR; GROWTH INHIBITOR; QUINAZOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

ARTICLE; AUTOREGULATION; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESISTANCE; ENZYME SYNTHESIS; HALF LIFE TIME; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; BIOSYNTHESIS; CELL CULTURE; COLON TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; PATHOLOGY;

COLONIC NEOPLASMS; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; OLIGORIBONUCLEOTIDES, ANTISENSE; QUINAZOLINES; THIOPHENES; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0035862164     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.2.415     Document Type: Article

References (41)

1. The catalytic mechanism and structure of thymidylate synthase
2. The mode of action of fluorouracil and its derivatives
3. Thymidylate synthetase - A target enzyme in cancer chemotherapy
4. Atomic structure of thymidylate synthase: Target for rational drug design
5. Structure-based discovery of inhibitors of thymidylate synthase
6. The role of thymidylate synthase as an RNA binding protein
7. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase
8. Identification of an RNA binding site for human thymidylate synthase
9. Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA
10. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma
11. The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme
12. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors
13. Repression of human thymidylate synthase mRNA translation by antisense 2′-O-methyl oligoribonucleotides
14. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents
15. A specificity comparison of four antisense types: Morpholino, 2′-O-methyl RNA, DNA and phosphorothioate DNA
16. Fluorouracil: Active in ZD1694 (tomudex)-resistant cell lines with markedly elevated thymidylate synthase levels
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line
19. Optimal lipofection reagent varies with the molecular modifications of the DNA
20. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin
21. Identification of in vivo target RNA sequences bound by thymidylate synthase
22. Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex
23. Regulation of p53 expression by thymidylate synthase
24. Synthesis and hybridization studies on two complementary nona(2′-O-methyl) ribonucleotides
25. Is irrelevant cleavage the price of antisense efficacy?
26. Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro
27. Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA
28. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription
29. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells
30. Participation of p53 protein in the cellular response to DNA damage
31. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage
32. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
33. Induction of cellular p53 activity by DNA-damaging agents and growth arrest
34. Negative feedback regulation of wild-type p53 biosynthesis
35. A translation repressor element resides in the 3′ untranslated region of human p53 mRNA
36. Translational regulation of human p53 gene expression
37. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors
38. Quantitation of thymidylate synthase, dihydrofolate reductase and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
39. Cell binding, uptake and cytosolic partition of HIV anti-gag phosphodiester oligonucleotides 3′-linked to cholesterol derivatives in macrophages
40. A novel, long-circulating and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDRI
41. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol